156 related articles for article (PubMed ID: 6594235)
21. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
22. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
Finch RG; Craddock C; Kelly J; Deaney NB
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
[TBL] [Abstract][Full Text] [Related]
24. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
[TBL] [Abstract][Full Text] [Related]
25. Imipenem/cilastatin.
Barza M
Eur J Clin Microbiol; 1984 Oct; 3(5):453-5. PubMed ID: 6594233
[No Abstract] [Full Text] [Related]
26. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
[TBL] [Abstract][Full Text] [Related]
27. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
Norrby SR; Rogers JD; Ferber F; Jones KH; Zacchei AG; Weidner LL; Demetriades JL; Gravallese DA; Hsieh JY
Antimicrob Agents Chemother; 1984 Nov; 26(5):707-14. PubMed ID: 6595962
[TBL] [Abstract][Full Text] [Related]
28. Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long-term hemodialysis.
Berman SJ; Sugihara JG; Nakamura JM; Kawahara KK; Wong EG; Musgrave JE; Wong LM; Siemsen AM
Am J Med; 1985 Jun; 78(6A):113-6. PubMed ID: 3859209
[TBL] [Abstract][Full Text] [Related]
29. Thienamycin: development of imipenen-cilastatin.
Kahan FM; Kropp H; Sundelof JG; Birnbaum J
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
[TBL] [Abstract][Full Text] [Related]
30. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
31. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of obstetrics and gynecology].
Cho N; Fukunaga K; Kunii K
Jpn J Antibiot; 1986 May; 39(5):1359-71. PubMed ID: 3463782
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates.
Bégué PC; Baron S; Challier P; Fontaine JL; Lasfargues G
Scand J Infect Dis Suppl; 1987; 52():40-5. PubMed ID: 3483288
[TBL] [Abstract][Full Text] [Related]
33. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
[TBL] [Abstract][Full Text] [Related]
34. Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
Williams PD; Bennett DB; Comereski CR
Antimicrob Agents Chemother; 1988 May; 32(5):758-60. PubMed ID: 3395104
[TBL] [Abstract][Full Text] [Related]
35. Renal tolerance of imipenem/cilastatin and other beta-lactam antibiotics in rats.
Sack K; Herhahn J; Marre R; Schulz E
Infection; 1985; 13 Suppl 1():S156-60. PubMed ID: 3863794
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
[TBL] [Abstract][Full Text] [Related]
37. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H
Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889
[TBL] [Abstract][Full Text] [Related]
38. Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections.
MacGregor RR; Gibson GA; Bland JA
Antimicrob Agents Chemother; 1986 Feb; 29(2):188-92. PubMed ID: 3459389
[TBL] [Abstract][Full Text] [Related]
39. Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.
Norrby SR; Alestig K; Björnegård B; Burman LA; Ferber F; Huber JL; Jones KH; Kahan FM; Kahan JS; Kropp H; Meisinger MA; Sundelof JG
Antimicrob Agents Chemother; 1983 Feb; 23(2):300-7. PubMed ID: 6573157
[TBL] [Abstract][Full Text] [Related]
40. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Clissold SP; Todd PA; Campoli-Richards DM
Drugs; 1987 Mar; 33(3):183-241. PubMed ID: 3552595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
